Case Study: NICE protects patient choice in AAA treatment with PLMR

NICE helps protect 5,000 lives a year with PLMR

The customer, NICE, faced a challenge when its draft guidance would have removed a key treatment option (EVAR) for patients with Abdominal Aortic Aneurysms, a condition that kills thousands annually in the UK. PLMR, through its Healthcomms Consulting team, provided public affairs services to support the Vascular and Venous APPG in coordinating a campaign against this change.

PLMR helped the APPG consolidate support from patient groups, clinicians, and politicians to engage with NICE officials and highlight the negative impact of the proposed guidance. As a result, NICE agreed to review and move away from its initial decision, preventing thousands from potentially receiving poorer treatment. This successful campaign by PLMR was later awarded Campaign of the Year at the 2019 PRCA Awards.

NICE